For patients with OSA undergoing stenting, the authors of this study suggested the risk of stent thrombosis might be reduced by cleaning or cutting out plaque before placing a stent, ensuring the stent is the largest size possible and using the most potent antiplatelet drugs
after the procedure to inhibit clots from forming.
It's a pick-your-poison kind of scenario, because some antiplatelet drugs
that cause excessive bleeding are also derived from snake venom.
KEY WORDS: Aspirin, Antiplatelet drugs
, Coronary artery bypass surgery.
Nevertheless, antithrombotic and antiplatelet drugs
use appears to have been neglected in this same period of time.
Adverse Effects With Dual Antiplatelet Drug
A partial list of current unmet medical needs Selection & Monitoring Efficacy of Antiplatelet Drugs
(Personalized or Precision Medicine) Genomic Response Classification (hypo, normo, hyer responder) Monitoring Dual Anti Platelet Therapy Verifying Patient Compliance with Drug Therapy Assessing Residual Platelet Reactivity Risk Assessments (Bleeding, Thrombosis) Activity in Oncology and Infectious Disease Patients Table 3.
The results from the above study thus reflect a need for more specific antiplatelet treatment regimens especially in diabetic subjects, which may include more potent agents or a combination with other antiplatelet drugs
The study published online today in the American Journal of Medicine provides the most up-to-date picture of European cardiologists' prescribing of antithrombotic treatment, which includes oral anticoagulation therapy (warfarin and the novel oral anticoagulants) and antiplatelet drugs
Various clinical studies have probed the effectiveness and risk profile of the newer antiplatelet drugs
in comparison with currently available drugs.
The Swedish version, Coagulation News, has been around for many years, but for the English translation, the chapter on new anticoagulants has been heavily revised, a new chapter added on antiplatelet drugs
, and other changes made.
Among the 6609 patients taking antiplatelet drugs
at baseline, B vitamins had no significant effect on the incidence of the primary outcome (15% vs.
Therapeutic measures including anticoagulation and antiplatelet drugs
have "revolutionized" the approach to acute coronary syndrome and improved clinical outcomes.